Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary shares, par value 0.002 GBP per share
-
Shares outstanding
-
147M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
5.3M
-
Shares change
-
-6.38M
-
Total reported value, excl. options
-
$59.8M
-
Value change
-
-$40.6M
-
Put/Call ratio
-
0.28
-
Number of buys
-
2
-
Number of sells
-
-8
-
Price
-
$11.30
Significant Holders of Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) as of Q1 2024
16 filings reported holding CNTA - Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share as of Q1 2024.
Centessa Pharmaceuticals plc - Ordinary shares, par value 0.002 GBP per share (CNTA) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.3M shares
of 147M outstanding shares and own 3.59% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (3.08M shares), MORGAN STANLEY (2.14M shares), CITADEL ADVISORS LLC (47K shares), JPMORGAN CHASE & CO (27.3K shares), Royal Bank of Canada (610 shares), NBC SECURITIES, INC. (138 shares), ACUTA CAPITAL PARTNERS, LLC (0 shares), Kynam Capital Management, LP (0 shares), Compagnie Lombard Odier SCmA (0 shares), and Woodline Partners LP (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.